Treatment of mucosal leishmaniasis with a lipid formulation of amphotericin B

被引:26
|
作者
Amato, Valdir Sabbaga [1 ]
Tuon, Felipe Francisco [1 ]
Campos, Aleia [1 ]
Bacha, Helio Arthur [1 ]
Nicodemo, Antonio Carlos [1 ]
Neto, Vicente Amato [1 ]
Shikanai-Yasuda, Maria Aparecida [1 ]
机构
[1] Univ Sao Paulo, Sch Med, Dept Infect & Parasit Dis, Sao Paulo, Brazil
关键词
D O I
10.1086/510494
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:311 / 312
页数:2
相关论文
共 50 条
  • [21] Treatment of visceral leishmaniasis with liposomal amphotericin B
    不详
    HOSPITAL MEDICINE, 2001, 62 (09): : 577 - 577
  • [22] Liposomal amphotericin B for the treatment of visceral leishmaniasis
    Bern, Caryn
    Adler-Moore, Jill
    Berenguer, Juan
    Boelaert, Marleen
    den Boer, Margriet
    Davidson, Robert N.
    Figueras, Concepcion
    Gradoni, Luigi
    Kafetzis, Dimitris A.
    Ritmeijer, Koert
    Rosenthal, Eric
    Royce, Catherine
    Russo, Rosario
    Sundar, Shyam
    Alvar, Jorge
    CLINICAL INFECTIOUS DISEASES, 2006, 43 (07) : 917 - 924
  • [23] Formulation of Amphotericin B in PEGylated Liposomes for Improved Treatment of Cutaneous Leishmaniasis by Parenteral and Oral Routes
    Ramos, Guilherme S.
    Vallejos, Virginia M. R.
    Borges, Gabriel S. M.
    Almeida, Raquel M.
    Alves, Izabela M.
    Aguiar, Marta M. G.
    Fernandes, Christian
    Guimaraes, Pedro P. G.
    Fujiwara, Ricardo T.
    Loiseau, Philippe M.
    Ferreira, Lucas A. M.
    Frezard, Frederic
    PHARMACEUTICS, 2022, 14 (05)
  • [24] Formulation and characterisation of a self-nanoemulsifying drug delivery system of amphotericin B for the treatment of leishmaniasis
    Khan, Momin
    Nadhman, Akhtar
    Shah, Walayat
    Khan, Imran
    Yasinzai, Masoom
    IET NANOBIOTECHNOLOGY, 2019, 13 (05) : 477 - 483
  • [25] Severe hepatic injury following lipid formulation of amphotericin B therapy for Visceral leishmaniasis in liver transplantation.
    Oreste, C
    Pempinello, R
    Ettore, S
    Oreste, P
    Ciro, E
    Giovanni, D
    LIVER TRANSPLANTATION, 2006, 12 (05) : C22 - C22
  • [26] Guidelines for the reconstitution of the correct amphotericin B lipid formulation
    Keady, Simon
    Panesar, Preet
    Damianos, Janet
    EJHP PRACTICE, 2010, 16 (03): : 78 - 80
  • [27] Role of the lipid formulation of amphotericin B in pediatric oncohematology
    Leverger, G
    PRESSE MEDICALE, 2000, 29 (22): : 1266 - 1267
  • [28] Efficacy and Safety of Liposomal Amphotericin B for the Treatment of Mucosal Leishmaniasis from the New World: A Retrospective Study
    Cunha, Mirella A.
    Leao, Aline C. Q.
    Soler, Rita de Cassia
    Lindoso, Jose Angelo L.
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2015, 93 (06): : 1214 - 1218
  • [29] Lipid nanoparticles for amphotericin delivery in the treatment of American tegumentary leishmaniasis
    de Souza, Regina Maia
    Maranhao, Raul Cavalcante
    Tavares, Elaine Rufo
    Filippin-Monteiro, Fabiola Branco
    Nicodemo, Antonio Carlos
    Morikawa, Aleksandra Tiemi
    Yamashiro Kanashiro, Edite Hatsumi
    Amato, Valdir Sabbaga
    DRUG DELIVERY AND TRANSLATIONAL RESEARCH, 2020, 10 (02) : 403 - 412
  • [30] Lipid nanoparticles for amphotericin delivery in the treatment of American tegumentary leishmaniasis
    Regina Maia de Souza
    Raul Cavalcante Maranhão
    Elaine Rufo Tavares
    Fabíola Branco Filippin-Monteiro
    Antônio Carlos Nicodemo
    Aleksandra Tiemi Morikawa
    Edite Hatsumi Yamashiro Kanashiro
    Valdir Sabbaga Amato
    Drug Delivery and Translational Research, 2020, 10 : 403 - 412